MAPT and Alzheimer disease: Although the impact of gender on Aβ and tau burden is unclear [81], a longitudinal study in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort revealed that women with positive CSF biomarkers suffered from faster neurodegeneration and cognitive deterioration than men [82].